跳至主要内容
临床试验/IRCT2015022321211N1
IRCT2015022321211N1已完成未知

Comparison of treatment outcomes between endoscopic injection of new bulking agent of Vantris® and open surgery of Gil-vernet in 1-10 year-aged children with primary vesicoureteral reflux(VUR)

Vice Chancellor Of Research Of Tabriz University Of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 year 至 10 years(—)
性别
All

入选标准

  • Iinclusion criteriae: 1)1-10 years of old ; 2) II to IV grade VURs, as defined below: a) Symptomatic UTIs(such as fever,dysuria,poor feeding, FTT); New renal scarring despite of antibiotic prophylaxis; bilateral VUR; Intolerance to prophylactic antibiotics; parent tendency to surgical repair. Exclusion criteriae: 1)Grades I and V ; 2) previously open or endoscopic surgeries on bladder or ureters ; 3) Anantomic malformations of urinary tract such as obstructive disorders or complete duplication of pyelocaliceal system ; 4)suspicion to or confirmed voiding disorder : a. presence of related clinical findings including abnormal neurologic exam or elimination disorder(instinal and urinary, with together); b.VCUG or ultrasonographic abnormalities such as bladder wall abnormalities or diverticuli ortrabeculation or decreased vesical capacity ; 5)Neurogenic bladder

排除标准

  • 未提供

研究者

发起方
Vice Chancellor Of Research Of Tabriz University Of Medical Sciences

相似试验